NDC 81927-201 – Imkeldi

Imatinib Mesylate 80 mg/mL · Solution · Oral

Human Prescription Drug

Product NDC81927-201

Product details

Brand name
Imkeldi
Generic name
Imatinib oral
Labeler
Shorla Oncology Inc.,
Dosage form
Solution
Route
Oral
Marketing category
NDA · NDA219097
Marketed since
December 19, 2024
Listing expires
December 31, 2026
Pharmacologic class
Kinase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Imkeldi →

Package NDC codes (1)

Package NDCDescriptionSince
81927-201-01140 mL in 1 BOTTLE (81927-201-01)Dec 19, 2024